A radiomics-based approach with automated segmentation for identifying symptomatic basilar artery plaques in acute

Jie Chen1, Wenwen He2, Long Yang3

  • 1Lauterbur Research Center for Biomedical Imaging, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China; Department of Biomedical Engineering, Chongqing University of Technology, Chongqing, China.

Insights

A new framework accurately identifies symptomatic basilar artery plaques in patients with intracranial atherosclerotic disease (ICAD). This AI-driven approach using MRI vessel wall imaging and a foundation model improves stroke risk stratification.

Area of Science:

  • Neurology
  • Radiology
  • Artificial Intelligence in Medicine

Background:

  • Intracranial atherosclerotic disease (ICAD) is a major cause of ischemic stroke.
  • Basilar artery atherosclerosis poses a significant risk for recurrent strokes.
  • Accurate identification of symptomatic plaques is crucial for effective treatment.

Purpose of the Study:

  • To develop and validate a framework for identifying symptomatic basilar artery plaques.
  • Integrate MRI vessel wall segmentation with a tabular foundation model for plaque characterization.
  • Enhance risk stratification and treatment planning for ICAD patients.

Main Methods:

  • Retrospective analysis of 256 patients with basilar artery stenosis.
  • Automated segmentation of basilar artery vessel wall using Vessel-SegNet on VWI.
  • Feature extraction (radiomics, morphology, signal intensity) and training of Tabular Prior-Fitted Network (TabPFN).

Main Results:

  • A radiomics-based model achieved an AUC of 0.887 for distinguishing symptomatic from asymptomatic plaques.
  • This significantly outperformed traditional feature-based models (AUC 0.784).
  • The framework demonstrated high accuracy, sensitivity, and specificity.

Conclusions:

  • The integrated framework accurately identifies symptomatic basilar artery plaques.
  • This AI-driven approach offers a scalable and objective tool for ICAD management.
  • Supports improved risk stratification and personalized treatment strategies.
Abstract